Vanguard Group’s Galmed Pharmaceuticals GLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
Sell
-177
Closed -$242K 4144
2015
Q4
$242K Buy
177
+15
+9% +$20.5K ﹤0.01% 3987
2015
Q3
$217K Buy
162
+17
+12% +$22.8K ﹤0.01% 4018
2015
Q2
$262K Buy
145
+50
+53% +$90.3K ﹤0.01% 3999
2015
Q1
$160K Buy
+95
New +$160K ﹤0.01% 4026